Edition:
United Kingdom

Aralez Pharmaceuticals Inc (ARLZ.OQ)

ARLZ.OQ on NASDAQ Stock Exchange Global Select Market

0.29USD
13 Jul 2018
Change (% chg)

$0.01 (+3.57%)
Prev Close
$0.28
Open
$0.29
Day's High
$0.30
Day's Low
$0.28
Volume
111,718
Avg. Vol
198,022
52-wk High
$2.98
52-wk Low
$0.27

Select another date:

Tue, May 8 2018

BRIEF-Aralez Pharmaceuticals Announces Discontinuation Of U.S. Commercial Operations, With Reductions In Operating Expenses

* ARALEZ PHARMACEUTICALS INC - DISCONTINUATION OF U.S. COMMERCIAL OPERATIONS, WITH SIGNIFICANT REDUCTIONS IN OPERATING EXPENSES

BRIEF-Aralez Pharmaceuticals Reports Q1 Loss Per Share Of $0.29

* 1Q 2018 NET REVENUES INCREASED TO $38.1 MILLION VERSUS $26.0 MILLION IN 1Q 2017

BRIEF-Aralez Pharmaceuticals Says Unit Entered Into Modification Of Contract

* ARALEZ PHARMA - UNIT ENTERED INTO MODIFICATION OF CONTRACT PURSUANT TO WHICH U.S. EXERCISED SECOND RENEWAL OPTION UNDER THAT VA NATIONAL CONTRACT

BRIEF-Aralez Pharmaceuticals Inc - ‍On March 13, Board Appointed Michael Kaseta As Company's CFO - SEC Filing

* ARALEZ PHARMACEUTICALS INC - ‍ON MARCH 13, BOARD APPOINTED MICHAEL KASETA AS COMPANY'S CFO - SEC FILING Source text (http://bit.ly/2p8Z0x1) Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Aralez Pharmaceuticals Posts Q4 Loss Per Share $0.68‍‍​

* ARALEZ ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

Select another date: